We in Pella are committed to the safety and
quality of our products and maintain an active pharmacovigilance program to
help ensure patients' safety, compliance and satisfaction and improve public
health.
Our Pharmacovigilance department manages a robust
pharmacovigilance system for the collection, collation, assessment and evaluation
of adverse events.
For complaints and adverse events reporting,
contact:
PellaQPPV@dermapharma.jo ,
+962 795905451
Or you can fill out the online report: